Artiva Biotherapeutics, Inc. (ARTV) vs Kyverna Therapeutics, Inc. (KYTX)

A side-by-side comparison of Artiva Biotherapeutics, Inc. and Kyverna Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Artiva Biotherapeutics, Inc. logo
ARTV
Artiva Biotherapeutics, Inc.
$355M
$7.27HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Kyverna Therapeutics, Inc. logo
KYTX
Kyverna Therapeutics, Inc.
$374M
$6.16HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — ARTV vs KYTX

growth of $100 · dividends reinvested · last 2y
ARTV -40.6% (-22.9%/yr)KYTX -36.9% (-20.5%/yr)KYTX compounded faster over this window
50100Start $10020252026$59$63
ARTV KYTX

ARTV vs KYTX: by the numbers

  • •KYTX is the larger company ($374M vs $355M market cap).

Metrics side by side

Valuation

MetricARTVKYTX
P/B ratio1.022.26

Profitability

MetricARTVKYTX
Gross margin0.00%0.00%
Operating margin0.00%0.00%
Net margin0.00%0.00%
ROE-26.14%-92.20%
ROIC-27.16%-80.67%

Go deeper

Full ARTV analysisFull KYTX analysisInteractive comparison tool

Dig into the metrics

Artiva Biotherapeutics ROEKyverna Therapeutics ROEArtiva Biotherapeutics operating marginKyverna Therapeutics operating marginArtiva Biotherapeutics revenue growthKyverna Therapeutics revenue growthArtiva Biotherapeutics free cash flowKyverna Therapeutics free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.